Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: A relation with NO-system
- 7 August 2009
- journal article
- Published by Elsevier BV in Regulatory Peptides
- Vol. 156 (1-3), 83-89
- https://doi.org/10.1016/j.regpep.2009.05.008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.Inflammopharmacology, 2006
- Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in ratsEuropean Journal of Pharmacology, 2005
- Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channelsAutonomic & Autacoid Pharmacology, 2005
- Doxorubicine-Congestive Heart Failure-Increased Big Endothelin-1 Plasma Concentration: Reversal by Amlodipine, Losartan, and Gastric Pentadecapeptide BPC157 in Rat and MouseJournal of Pharmacological Sciences, 2004
- Crosstalk Between Endothelin and Nitric Oxide in the Control of Vascular ToneHeart Failure Reviews, 2001
- The Role of Nitric Oxide in Digoxin‐Induced Arrhythmias in Guinea‐Pigs*Basic & Clinical Pharmacology & Toxicology, 1999
- The influence of a novel pentadecapeptide, BPC 157, on NG-nitro-l-arginine methylester and l-arginine effects on stomach mucosa integrity and blood pressureEuropean Journal of Pharmacology, 1997
- Arrhythmogenic Action of Endothelin Peptides in Isolated Perfused Whole Hearts from Guinea Pigs and RatsPharmacology, 1996
- Effects of NO Modulation on Cardiac Arrhythmias in the Rat Isolated HeartCirculation Research, 1995
- The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptidesLife Sciences, 1994